David Young
Fondateur chez PROCESSA PHARMACEUTICALS, INC.
Fortune : 147 105 $ au 31/05/2024
Profil
David Young was the founder of GloboMax LLC, founded in 2003, where he held the title of Chief Executive Officer.
He is also the founder of Processa Pharmaceuticals, Inc., founded in 2011, where he currently holds the title of Director, President-Research & Development.
Additionally, he was the founder of Promet Therapeutics LLC, founded in 2015, where he held the title of Chief Executive & Financial Officer.
Dr. Young's former job positions include Director, Chief Executive & Financial Officer at Heatwurx, Inc. He also worked as the Managing Director-Clinical Research Unit at the University of Maryland.
From 2006 to 2009, he served as the President & Executive Director of AGI Therapeutics, Inc. and AGI Therapeutics Plc.
He was the Director-Pharmacokinetics & Associate Professor at the University of Maryland School of Pharmacy from 1986 to 1997.
From 2006 to 2014, he held the position of Chief Scientific Officer at Questcor Pharmaceuticals, Inc. He was also the EVP-Strategic Drug Development Division at ICON plc from 2003 to 2006.
Dr. Young's education includes a graduate degree from the University of Wisconsin and an undergraduate degree from the University of California, Berkeley.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 22/04/2024 | 99 395 ( 3,48% ) | 147 105 $ | 31/05/2024 |
Postes actifs de David Young
| Sociétés | Poste | Début |
|---|---|---|
| PROCESSA PHARMACEUTICALS, INC. | Fondateur | 29/03/2011 |
Anciens postes connus de David Young
| Sociétés | Poste | Fin |
|---|---|---|
| QUESTCOR PHARMACEUTICALS INC | Directeur Technique/Scientifique/R&D | 01/01/2014 |
AGI Therapeutics Plc
 AGI Therapeutics Plc Pharmaceuticals: MajorHealth Technology AGI Therapeutics Plc provides pharmaceutical services. The firm engages in development and commercialization of differentiated drug products to treat unmet medical needs, including conditions which qualify for orphan drug status. The company was founded by John Devane and Patrick Ashe in 2003 and is headquartered in Dublin, Ireland. | President | 01/10/2009 |
| AGI Therapeutics, Inc. | President | - |
| ICON PUBLIC LIMITED COMPANY | Corporate Officer/Principal | - |
| GloboMax LLC | Directeur Général | - |
Formation de David Young
| University of Southern California | Doctorate Degree |
| University of Wisconsin | Graduate Degree |
| University of California, Berkeley | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| ICON PUBLIC LIMITED COMPANY | Commercial Services |
| PROCESSA PHARMACEUTICALS, INC. | Health Technology |
| Entreprise privées | 6 |
|---|---|
Questcor Pharmaceuticals, Inc.
 Questcor Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Questcor Pharmaceuticals, Inc. was engaged in development, marketing and sale of prescription drugs. It operated as a biopharmaceutical company which focuses on the treatment of patients with serious, difficult-to-treat autoimmune and inflammatory disorders. The company's primary product was H.P. Acthar Gel, an injectable drug for the treatment of proteinuria in the nephrotic syndrome of the idiopathic type, or NS, the treatment of acute exacerbations of multiple sclerosis, or MS, in adults, the treatment of infantile spasms, or IS, in infants and children under two years of age, and the treatment of certain rheumatology related conditions, including the treatment of the rare and closely related neuromuscular disorders dermatomyositis and polymyositis. Questcor Pharmaceuticals was founded in September 1992 and was headquartered in Anaheim, CA. | Health Technology |
AGI Therapeutics Plc
AGI Therapeutics Plc Pharmaceuticals: MajorHealth Technology AGI Therapeutics Plc provides pharmaceutical services. The firm engages in development and commercialization of differentiated drug products to treat unmet medical needs, including conditions which qualify for orphan drug status. The company was founded by John Devane and Patrick Ashe in 2003 and is headquartered in Dublin, Ireland. | Health Technology |
Heatwurx, Inc.
 Heatwurx, Inc. Trucks/Construction/Farm MachineryProducer Manufacturing Heatwurx, Inc. engages in the development and sale of asphalt and pavement repair equipment. The company was founded by Larry C. Griffin and David J. Eastman on March 29, 2011 and is headquartered in Gardena, CA. | Producer Manufacturing |
| AGI Therapeutics, Inc. | |
| GloboMax LLC | |
Promet Therapeutics LLC
 Promet Therapeutics LLC Pharmaceuticals: MajorHealth Technology Promet Therapeutics LLC engage in the clinical stage biotechnology company that develops drug products to treat patients who have suboptimal or no treatment alternatives. The company was founded on September 16, 2015 and is headquartered in Ellicott City, MD. | Health Technology |
